A digital toolkit with patient scripts, risk calculator comparisons and more could help primary care and OB/GYN providers ...
More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 did not undergo testing for BRCA mutations, according to a retrospective analysis.Less than half ...
Being a physician is a privilege because your skills can truly change a life.Restoring sight gives someone back their ...
The FDA has approved berotralstat oral pellets for prophylactic use in patients aged 2 to than 12 years with hereditary ...
Is omission of the sentinel lymph node biopsy safe in early breast cancer in patients treated with breast conserving therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback